FDA issues policy clarifications for drug compounders during the Covid-19 pandemic.
FDA posts a question-and-answer document on drug manufacturing and site changes during the Covid-19 pandemic.
FDA grants Acceleron Pharma a breakthrough therapy designation for sotatercept and its use in treating patients with pulmonary arterial hypertension.
FDA says Dynamic Stem Cell Therapy is marketing unapproved cellular products as treatments for many diseases and conditions.
Lannett says FDA has granted it a 6/9 Biosimilar Biological Product Development Type 2 meeting to plan next steps for the clinical development of its ...
FDA extends by three months its review of a Roche NDA for risdiplam and its use in treating spinal muscular atrophy.
Multiple former FDA officials question the wisdom of the agency granting an emergency use authorization for two malaria medicines to be used against t...
The Justice Department says Pentax Medical is paying $43 million to resolve criminal charges resulting from its decision not to use revised FDA cleani...